Teva Pharmaceuticals has opened a new $110 million plant in Hungary, set to be one of the largest sterile medicines plants in the world.
The 15,000 square meter plant will work primarily in oncology therapeutics, and will produce 160-200 million units of injectables a year.
Teva has been operating in Hungary since 1993, operating a tablet production facility, an advanced pharmaceutical ingredients manufacturing plant, and now the sterile plant, and employs 3,5000 Hungarians.
About the Author: Malkah Fleisher is a graduate of Cardozo Law School in New York City. She is an editor/staff writer at JewishPress.com and co-hosts a weekly Israeli FM radio show. Malkah lives with her husband and two children on the Mount of Olives in Jerusalem.
If you don't see your comment after publishing it, refresh the page.